Efficacy of Switching to Bilastine, a Histamine H1 Receptor Antagonist, in Patients With Chronic Spontaneous Urticaria (H1-Switch): Study Protocol for a Randomized Controlled Trial
Trials - United Kingdom
doi 10.1186/s13063-019-3878-2
Full Text
Open PDFAbstract
Available in full text
Date
January 6, 2020
Authors
Publisher
Springer Science and Business Media LLC